By Helgi Analytics - September 16, 2020
Pilulka made a net profit of CZK 82.3 mil with revenues of CZK 4,267 mil in 2024, up by 101% and up by 26.3%, respe...
By Helgi Analytics - September 16, 2020
Pilulka stock traded at CZK 900 per share at the end 2024 translating into a market capitalization of USD 40.1 mil. Since the end...
By Helgi Analytics - September 16, 2020
...
| Profit Statement | 2022 | 2023 | 2024 | |
| Sales | CZK mil | 2,679 | 3,378 | 4,267 |
| Gross Profit | CZK mil | 734 | 936 | 1,192 |
| EBITDA | CZK mil | 49.8 | 93.1 | 147 |
| EBIT | CZK mil | 11.0 | 44.6 | 86.6 |
| Financing Cost | CZK mil | 2.91 | 3.61 | 4.31 |
| Pre-Tax Profit | CZK mil | 8.12 | 41.0 | 82.3 |
| Net Profit | CZK mil | 8.12 | 41.0 | 82.3 |
| Dividends | CZK mil | 0 | 0 | 0 |
| Balance Sheet | 2022 | 2023 | 2024 | |
| Total Assets | CZK mil | 650 | 788 | 989 |
| Non-Current Assets | CZK mil | 152 | 173 | 190 |
| Current Assets | CZK mil | 498 | 615 | 800 |
| Working Capital | CZK mil | -15.3 | 4.04 | 18.8 |
| Shareholders' Equity | CZK mil | 186 | 222 | 295 |
| Liabilities | CZK mil | 464 | 566 | 694 |
| Total Debt | CZK mil | 104 | 129 | 154 |
| Net Debt | CZK mil | -9.85 | -10.6 | -60.8 |
| Ratios | 2022 | 2023 | 2024 | |
| ROE | % | 5.88 | 21.2 | 31.8 |
| ROCE | % | 6.42 | 26.1 | 42.6 |
| Gross Margin | % | 27.4 | 27.7 | 27.9 |
| EBITDA Margin | % | 1.86 | 2.76 | 3.44 |
| EBIT Margin | % | 0.412 | 1.32 | 2.03 |
| Net Margin | % | 0.303 | 1.21 | 1.93 |
| Net Debt/EBITDA | -0.198 | -0.114 | -0.414 | |
| Net Debt/Equity | % | -5.30 | -4.78 | -20.6 |
| Cost of Financing | % | 3.06 | 3.10 | 3.05 |
| Valuation | 2022 | 2023 | 2024 | |
| Market Capitalisation | USD mil | 40.1 | 40.1 | 40.1 |
| Enterprise Value (EV) | USD mil | 39.6 | 39.6 | 37.4 |
| Number Of Shares | mil | 1.00 | 1.00 | 1.00 |
| Share Price | CZK | 900 | 900 | 900 |
| EV/EBITDA | 17.4 | 9.31 | 5.56 | |
| EV/Sales | 0.324 | 0.256 | 0.192 | |
| Price/Earnings (P/E) | 91.1 | 22.5 | 11.5 | |
| Price/Book Value (P/BV) | 4.84 | 4.06 | 3.05 | |
| Dividend Yield | % | 0 | 0 | 0 |
Get all company financials in excel:
| overview | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| income statement | ||||||||
| Sales | CZK mil | |||||||
| Gross Profit | CZK mil | |||||||
| EBIT | CZK mil | |||||||
| Net Profit | CZK mil | |||||||
| ROE | % | ... | ||||||
| EBIT Margin | % | |||||||
| Net Margin | % | |||||||
| Employees | ... | ... | ... | ... | ||||
| balance sheet | ||||||||
| Total Assets | CZK mil | |||||||
| Non-Current Assets | CZK mil | |||||||
| Current Assets | CZK mil | |||||||
| Shareholders' Equity | CZK mil | |||||||
| Liabilities | CZK mil | |||||||
| Non-Current Liabilities | CZK mil | |||||||
| Current Liabilities | CZK mil | |||||||
| Net Debt/EBITDA | ||||||||
| Net Debt/Equity | % | |||||||
| Cost of Financing | % | ... | ||||||
| cash flow | ||||||||
| Total Cash From Operations | CZK mil | |||||||
| Total Cash From Investing | CZK mil | |||||||
| Total Cash From Financing | CZK mil | |||||||
| Net Change In Cash | CZK mil | |||||||
| valuation | ||||||||
| Market Capitalisation | USD mil | |||||||
| Enterprise Value (EV) | USD mil | |||||||
| Number Of Shares | mil | |||||||
| Share Price | CZK | |||||||
| Price/Earnings (P/E) | ... | |||||||
| Price/Cash Earnings (P/CE) | ||||||||
| EV/EBITDA | ||||||||
| Price/Book Value (P/BV) | ||||||||
| Dividend Yield | % |
| income statement | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| income statement | ||||||||
| Sales | CZK mil | |||||||
| Cost of Goods & Services | CZK mil | |||||||
| Gross Profit | CZK mil | |||||||
| Staff Cost | CZK mil | ... | ... | ... | ... | ... | ... | |
| EBITDA | CZK mil | |||||||
| Depreciation | CZK mil | |||||||
| EBIT | CZK mil | |||||||
| Net Financing Cost | CZK mil | |||||||
| Financing Cost | CZK mil | |||||||
| Financing Income | CZK mil | |||||||
| FX (Gain) Loss | CZK mil | |||||||
| Extraordinary Cost | CZK mil | |||||||
| Pre-Tax Profit | CZK mil | |||||||
| Tax | CZK mil | |||||||
| Minorities | CZK mil | ... | ||||||
| Net Profit | CZK mil | |||||||
| Net Profit Avail. to Common | CZK mil | ... | ||||||
| Dividends | CZK mil | |||||||
| growth rates | ||||||||
| Total Revenue Growth | % | |||||||
| Operating Cost Growth | % | ... | ||||||
| Staff Cost Growth | % | ... | ... | ... | ... | ... | ... | |
| EBITDA Growth | % | |||||||
| EBIT Growth | % | |||||||
| Pre-Tax Profit Growth | % | |||||||
| Net Profit Growth | % | ... | ... | |||||
| ratios | ||||||||
| ROE | % | ... | ||||||
| ROA | % | |||||||
| ROCE | % | ... | ||||||
| Gross Margin | % | |||||||
| EBITDA Margin | % | |||||||
| EBIT Margin | % | |||||||
| Net Margin | % | |||||||
| Payout Ratio | % | |||||||
| Cost of Financing | % | ... | ||||||
| Net Debt/EBITDA |
| balance sheet | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| balance sheet | ||||||||
| Cash & Cash Equivalents | CZK mil | |||||||
| Receivables | CZK mil | |||||||
| Inventories | CZK mil | |||||||
| Other ST Assets | CZK mil | |||||||
| Current Assets | CZK mil | |||||||
| Property, Plant & Equipment | CZK mil | |||||||
| LT Investments & Receivables | CZK mil | |||||||
| Intangible Assets | CZK mil | |||||||
| Non-Current Assets | CZK mil | |||||||
| Total Assets | CZK mil | |||||||
| Trade Payables | CZK mil | |||||||
| Short-Term Debt | CZK mil | |||||||
| Other ST Liabilities | CZK mil | |||||||
| Current Liabilities | CZK mil | |||||||
| Long-Term Debt | CZK mil | |||||||
| Other LT Liabilities | CZK mil | |||||||
| Non-Current Liabilities | CZK mil | |||||||
| Liabilities | CZK mil | |||||||
| Share Capital | CZK mil | |||||||
| Equity Before Minority Interest | CZK mil | |||||||
| Minority Interest | CZK mil | |||||||
| Equity | CZK mil | |||||||
| growth rates | ||||||||
| Total Asset Growth | % | |||||||
| Shareholders' Equity Growth | % | |||||||
| Net Debt Growth | % | ... | ||||||
| Total Debt Growth | % | ... | ||||||
| ratios | ||||||||
| Total Debt | CZK mil | |||||||
| Net Debt | CZK mil | |||||||
| Working Capital | CZK mil | |||||||
| Capital Employed | CZK mil | |||||||
| Net Debt/Equity | % | |||||||
| Current Ratio | ||||||||
| Quick Ratio |
| cash flow | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| cash flow | ||||||||
| Net Profit | CZK mil | |||||||
| Depreciation | CZK mil | |||||||
| Non-Cash Items | CZK mil | |||||||
| Change in Working Capital | CZK mil | |||||||
| Total Cash From Operations | CZK mil | |||||||
| Capital Expenditures | CZK mil | |||||||
| Net Change in LT Investment | CZK mil | |||||||
| Total Cash From Investing | CZK mil | |||||||
| Dividends Paid | CZK mil | |||||||
| Issuance Of Shares | CZK mil | |||||||
| Issuance Of Debt | CZK mil | |||||||
| Total Cash From Financing | CZK mil | |||||||
| Effect of FX Rates | CZK mil | |||||||
| Net Change In Cash | CZK mil | |||||||
| ratios | ||||||||
| Days Sales Outstanding | days | |||||||
| Days Sales Of Inventory | days | |||||||
| Days Payable Outstanding | days | |||||||
| Cash Conversion Cycle | days | |||||||
| Cash Earnings | CZK mil | |||||||
| Free Cash Flow | CZK mil | |||||||
| Capital Expenditures (As % of Sales) | % |
| other ratios | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Employees | ... | ... | ... | ... | ||||
| Cost Per Employee | USD per month | ... | ... | ... | ... | ... | ... | |
| Cost Per Employee (Local Currency) | CZK per month | ... | ... | ... | ... | ... | ... | |
| Operating Cost (As % of Sales) | % | |||||||
| Staff Cost (As % of Sales) | % | ... | ... | ... | ... | ... | ... | |
| Effective Tax Rate | % | |||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | |||
| Customers | mil |
| valuation | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Market Capitalisation | USD mil | |||||||
| Enterprise Value (EV) | USD mil | |||||||
| Number Of Shares | mil | |||||||
| Share Price | CZK | |||||||
| EV/EBITDA | ||||||||
| Price/Earnings (P/E) | ... | |||||||
| Price/Cash Earnings (P/CE) | ||||||||
| P/FCF | ||||||||
| Price/Book Value (P/BV) | ||||||||
| Dividend Yield | % | |||||||
| Free Cash Flow Yield | % | |||||||
| Earnings Per Share (EPS) | CZK | ... | ||||||
| Cash Earnings Per Share | CZK | |||||||
| Free Cash Flow Per Share | CZK | |||||||
| Book Value Per Share | CZK | |||||||
| Dividend Per Share | CZK | |||||||
| EV/Sales | ||||||||
| EV/EBIT | ||||||||
| EV/Free Cash Flow | ||||||||
| EV/Capital Employed | ||||||||
| Earnings Per Share Growth | % | ... | ... | |||||
| Cash Earnings Per Share Growth | % | ... | ||||||
| Book Value Per Share Growth | % | ... | ||||||
| Market Value per Customer | USD | |||||||
| Sales per Customer | USD | |||||||
| EBITDA per Customer | USD | |||||||
| Net Profit per Customer | USD |
| clients & arpu | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Customers | mil | |||||||
| Customers (Czechia) | mil | |||||||
| ARPU from Total Business | CZK per month |
Get all company financials in excel:
By Helgi Analytics - September 16, 2020
...
By Helgi Analytics - September 16, 2020
...
By Helgi Analytics - September 16, 2020
...
By Helgi Analytics - September 16, 2020
...
By Helgi Analytics - September 16, 2020
...
By Helgi Analytics - September 16, 2020
...
By Helgi Analytics - September 16, 2020
Pilulka made a net profit of CZK 82.3 mil with revenues of CZK 4,267 mil in 2024, up by 101% and up by 26.3%, respectively, compared to the previous year. This translates into a net margin of 1.93%. Historically, between 2018 and 2024, the firm’s ...
By Helgi Analytics - September 16, 2020
Pilulka invested a total of CZK 68.2 mil in 2024, up 6.23% compared to the previous year. Historically, between 2018 - 2024, the company's investments stood at a high of CZK 68.2 mil in 2024 and a low of CZK 28.8 mil in 2020. As a per...
By Helgi Analytics - September 16, 2020
Pilulka made a net profit of CZK 82.3 mil with revenues of CZK 4,267 mil in 2024, up by 101% and up by 26.3%, respectively, compared to the previous year. This translates into a net margin of 1.93%. On the operating level, EBITDA reached CZK 147 mil, up...
By Helgi Analytics - September 16, 2020
Pilulka made a net profit of CZK 82.3 mil in 2024, up 101% compared to the previous year. Historically, between 2018 and 2024, the company's net profit reached a high of CZK 82.3 mil in 2024 and a low of CZK -58.5 mil in 2019. The result implies a return ...
Pilulka has been growing its sales by 26.4% a year on average in the last 5 years. EBITDA has grown by 504% during that time to total of CZK 147 mil in 2024, or 3.44% of sales. That’s compared to 1.65% average margin seen in last five years.
The company netted CZK 82.3 mil in 2024 implying ROE of 31.8% and ROCE of 42.6%. Again, the average figures were -0.920% and 0.964%, respectively when looking at the previous 5 years.
Pilulka’s net debt amounted to CZK -60.8 mil at the end of 2024, or -20.6% of equity. When compared to EBITDA, net debt was -0.414x, down when compared to average of 0.808x seen in the last 5 years.
Pilulka stock traded at CZK 900 per share at the end of 2024 resulting in a market capitalization of USD 40.1 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 5.56x and price to earnings (PE) of 11.5x as of 2024.
Helgi Analytics 
